High-impact chronic pain in sickle cell disease: insights from the Pain in Sickle Cell Epidemiology Study (PiSCES)

The US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care activities as having high-impact chronic pain (HICP). High-impact chronic pain has not been examined among individuals with CP and sickle cell...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pain (Amsterdam) Jg. 165; H. 10; S. 2364
Hauptverfasser: Jagtiani, Ashna, Chou, Eric, Gillespie, Scott E, Liu, Katie, Krishnamurti, Lakshmanan, McClish, Donna, Smith, Wally R, Bakshi, Nitya
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 01.10.2024
Schlagworte:
ISSN:1872-6623, 1872-6623
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract The US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care activities as having high-impact chronic pain (HICP). High-impact chronic pain has not been examined among individuals with CP and sickle cell disease (SCD). We analyzed data from 63 individuals with SCD and CP who completed at least 5 months of pain diaries in the Pain in Sickle Cell Epidemiology Study (PiSCES). Forty-eight individuals met the definition for HICP, which was operationalized in this study as reporting pain interference on more than half of diary days. Compared with individuals without HICP, individuals with HICP experienced higher mean daily pain intensity, particularly on days without crises. They also experienced a greater proportion of days with pain, days with healthcare utilization, and days with home opioid use and higher levels of stress. They did not have a statistically significantly higher proportion of days with crises or experience higher mean daily pain intensity on days with crises. Individuals with HICP experienced worse physical functioning and worse physical health compared with those without HICP, controlling for mean pain intensity, age, sex, and education. The results of this study support that HICP is a severely affected subgroup of those with CP in SCD and is associated with greater pain burden and worse health outcomes. The findings from this study should be confirmed prospectively in a contemporary cohort of individuals with SCD.
AbstractList The US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care activities as having high-impact chronic pain (HICP). High-impact chronic pain has not been examined among individuals with CP and sickle cell disease (SCD). We analyzed data from 63 individuals with SCD and CP who completed at least 5 months of pain diaries in the Pain in Sickle Cell Epidemiology Study (PiSCES). Forty-eight individuals met the definition for HICP, which was operationalized in this study as reporting pain interference on more than half of diary days. Compared with individuals without HICP, individuals with HICP experienced higher mean daily pain intensity, particularly on days without crises. They also experienced a greater proportion of days with pain, days with healthcare utilization, and days with home opioid use and higher levels of stress. They did not have a statistically significantly higher proportion of days with crises or experience higher mean daily pain intensity on days with crises. Individuals with HICP experienced worse physical functioning and worse physical health compared with those without HICP, controlling for mean pain intensity, age, sex, and education. The results of this study support that HICP is a severely affected subgroup of those with CP in SCD and is associated with greater pain burden and worse health outcomes. The findings from this study should be confirmed prospectively in a contemporary cohort of individuals with SCD.ABSTRACTThe US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care activities as having high-impact chronic pain (HICP). High-impact chronic pain has not been examined among individuals with CP and sickle cell disease (SCD). We analyzed data from 63 individuals with SCD and CP who completed at least 5 months of pain diaries in the Pain in Sickle Cell Epidemiology Study (PiSCES). Forty-eight individuals met the definition for HICP, which was operationalized in this study as reporting pain interference on more than half of diary days. Compared with individuals without HICP, individuals with HICP experienced higher mean daily pain intensity, particularly on days without crises. They also experienced a greater proportion of days with pain, days with healthcare utilization, and days with home opioid use and higher levels of stress. They did not have a statistically significantly higher proportion of days with crises or experience higher mean daily pain intensity on days with crises. Individuals with HICP experienced worse physical functioning and worse physical health compared with those without HICP, controlling for mean pain intensity, age, sex, and education. The results of this study support that HICP is a severely affected subgroup of those with CP in SCD and is associated with greater pain burden and worse health outcomes. The findings from this study should be confirmed prospectively in a contemporary cohort of individuals with SCD.
The US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care activities as having high-impact chronic pain (HICP). High-impact chronic pain has not been examined among individuals with CP and sickle cell disease (SCD). We analyzed data from 63 individuals with SCD and CP who completed at least 5 months of pain diaries in the Pain in Sickle Cell Epidemiology Study (PiSCES). Forty-eight individuals met the definition for HICP, which was operationalized in this study as reporting pain interference on more than half of diary days. Compared with individuals without HICP, individuals with HICP experienced higher mean daily pain intensity, particularly on days without crises. They also experienced a greater proportion of days with pain, days with healthcare utilization, and days with home opioid use and higher levels of stress. They did not have a statistically significantly higher proportion of days with crises or experience higher mean daily pain intensity on days with crises. Individuals with HICP experienced worse physical functioning and worse physical health compared with those without HICP, controlling for mean pain intensity, age, sex, and education. The results of this study support that HICP is a severely affected subgroup of those with CP in SCD and is associated with greater pain burden and worse health outcomes. The findings from this study should be confirmed prospectively in a contemporary cohort of individuals with SCD.
Author McClish, Donna
Krishnamurti, Lakshmanan
Jagtiani, Ashna
Liu, Katie
Bakshi, Nitya
Chou, Eric
Gillespie, Scott E
Smith, Wally R
Author_xml – sequence: 1
  givenname: Ashna
  surname: Jagtiani
  fullname: Jagtiani, Ashna
  organization: Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, Georgia, United States, Dr. Nitya Bakshi is now with the Division of Pediatric Hematology-Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States
– sequence: 2
  givenname: Eric
  surname: Chou
  fullname: Chou, Eric
  organization: Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, Georgia, United States, Dr. Nitya Bakshi is now with the Division of Pediatric Hematology-Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States
– sequence: 3
  givenname: Scott E
  surname: Gillespie
  fullname: Gillespie, Scott E
  organization: Department of Pediatrics, Pediatric Biostatistics Core, Emory University, Atlanta, Georgia, United States
– sequence: 4
  givenname: Katie
  surname: Liu
  fullname: Liu, Katie
  organization: Department of Pediatrics, Pediatric Biostatistics Core, Emory University, Atlanta, Georgia, United States
– sequence: 5
  givenname: Lakshmanan
  surname: Krishnamurti
  fullname: Krishnamurti, Lakshmanan
  organization: Division of Pediatric Hematology-Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States
– sequence: 6
  givenname: Donna
  surname: McClish
  fullname: McClish, Donna
  organization: Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, United States
– sequence: 7
  givenname: Wally R
  surname: Smith
  fullname: Smith, Wally R
  organization: Division of General Internal Medicine, Department of Medicine, Virginia Commonwealth University, Richmond, Virginia, United States
– sequence: 8
  givenname: Nitya
  orcidid: 0000-0002-0876-9506
  surname: Bakshi
  fullname: Bakshi, Nitya
  organization: Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Atlanta, Georgia, United States, Dr. Nitya Bakshi is now with the Division of Pediatric Hematology-Oncology, Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, United States
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38787626$$D View this record in MEDLINE/PubMed
BookMark eNpNkE1rwzAMhs3oWD-2v7D52B3S2XJqJ7uN0K2DwgrZzsGxndZdvhYnh_77JrSDCoGEePQivVM0KqvSIPREyYKSULwcFrW05YJcBQMON2hCAwEe58BGV_0YTZ079BAAhHdozAIRCA58gpq13e09W9RStVjtm6q0Cg_auE9n1W9usDJ5jrV1Rjrz2s9dv9I6nDVVgdu9wdsLHp_xaMBXtdWmsFVe7Y44bjt9xPOtjaNV_HyPbjOZO_NwqTP08776jtbe5uvjM3rbeMoXZLhbGT9TwMMsZMKXWcBSoJwHRIIUqaJaMcGWepkC0zpc-jT0fU4VDQnTGQQwQ_Ozbt1Uf51xbVJYN_wiS1N1LmGEE9b7IKBHHy9olxZGJ3VjC9kck3-f4ARwGGyr
CitedBy_id crossref_primary_10_1097_j_pain_0000000000003773
crossref_primary_10_3390_cells14030194
crossref_primary_10_1182_bloodadvances_2024013953
ContentType Journal Article
Copyright Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.
Copyright_xml – notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/j.pain.0000000000003262
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1872-6623
ExternalDocumentID 38787626
Genre Journal Article
GrantInformation_xml – fundername: NHLBI NIH HHS
  grantid: K23 HL140142
– fundername: NHLBI NIH HHS
  grantid: R01 HL064122
– fundername: NHLBI NIH HHS
  grantid: R03 HL162694
– fundername: NCATS NIH HHS
  grantid: UL1 TR001863
– fundername: NCATS NIH HHS
  grantid: UL1 TR002378
GroupedDBID ---
--K
026
0R~
123
1B1
1~5
4.4
71M
AAAAV
AAAXR
AACTN
AAGIX
AAHPQ
AAIQE
AAMOA
AAQKA
AARTV
AASCR
AASXQ
AAUEB
AAXQO
ABASU
ABBUW
ABDIG
ABIVO
ABJNI
ABLJU
ABOCM
ABPXF
ABVCZ
ABXVJ
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACNWC
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADGGA
ADHPY
AEKER
AENEX
AFBFQ
AFDTB
AFMBP
AFSOK
AGGSO
AHOMT
AHQNM
AHVBC
AHXIK
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKRWK
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BOYCO
BQLVK
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
EBS
ECM
EEVPB
EIF
ERAAH
EX3
F5P
FCALG
FDB
GNXGY
GQDEL
HLJTE
HMQ
HZ~
IHE
IKREB
IKYAY
L-C
L7B
MJL
MO0
N9A
NPM
O-L
O9-
OBH
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OXXIT
OZT
P2P
RLZ
RPZ
SCC
SEL
SES
SEW
TEORI
TSPGW
TWZ
7X8
ACBKD
ADKSD
ADSXY
~HD
ID FETCH-LOGICAL-c4702-66ce4fc269f9374af83b216680a2a7bc1dc3735d5b23dd954194461c1903df282
IEDL.DBID 7X8
ISICitedReferencesCount 2
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001313860100019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1872-6623
IngestDate Sun Nov 09 09:50:56 EST 2025
Tue May 06 01:31:48 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association for the Study of Pain.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4702-66ce4fc269f9374af83b216680a2a7bc1dc3735d5b23dd954194461c1903df282
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0876-9506
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11404329
PMID 38787626
PQID 3060378772
PQPubID 23479
ParticipantIDs proquest_miscellaneous_3060378772
pubmed_primary_38787626
PublicationCentury 2000
PublicationDate 2024-October
PublicationDateYYYYMMDD 2024-10-01
PublicationDate_xml – month: 10
  year: 2024
  text: 2024-October
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Pain (Amsterdam)
PublicationTitleAlternate Pain
PublicationYear 2024
SSID ssj0002229
Score 2.4772296
Snippet The US National Pain Strategy recommends identifying individuals with chronic pain (CP) who experience substantial restriction in work, social, or self-care...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 2364
SubjectTerms Adolescent
Adult
Anemia, Sickle Cell - complications
Anemia, Sickle Cell - epidemiology
Chronic Pain - epidemiology
Female
Humans
Male
Middle Aged
Pain Measurement - methods
Young Adult
Title High-impact chronic pain in sickle cell disease: insights from the Pain in Sickle Cell Epidemiology Study (PiSCES)
URI https://www.ncbi.nlm.nih.gov/pubmed/38787626
https://www.proquest.com/docview/3060378772
Volume 165
WOSCitedRecordID wos001313860100019&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS8MwEA_qRHzx-2N-EcEHfYhrk7ZpfREZG744ClPYW0mTBqbSzVWF_ffetRl7EgRL6UNJIblcL79L7u5HyBUXgns2EgwMn2JBaHIG67hlQkiufGuMCE1NNiEHg3g0SlK34Va5sMqFTawNtZlo3CPvALT1BGiX5PfTD4asUXi66ig0VklLAJRBrZajZbVw5KpGhyuWnEWwzi_iuxLZeb2dgufdVC90FwAZ_jvOrNeb_vZ_e7pDthzSpA-NauySlaLcIxtP7ix9n8wwxIM1WZJUNzVyKXaXwg1z9_ZeUNzWp-4M5w7eV-jKVxRzUiggR5q65sOmeReb95acs3OKYYpzep2Oh93e8OaAvPR7z91H5hgYmA6kh0LTRWA1jxILMCZQNhY596Mo9hRXMte-0ULCbIY5F8YkYeAn4F76GlCGMBa8uUOyVk7K4phQDVZXWlP4BVeBiBKVK64TrH6XYzKuaZPLhTQz0HAcnyqLyVeVLeXZJkfNlGTTphRHJmKJ5jw6-cPXp2STAyJpIvHOSMvC_12ck3X9_TmuZhe16sBzkD79AM4Jy1s
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=High-impact+chronic+pain+in+sickle+cell+disease%3A+insights+from+the+Pain+in+Sickle+Cell+Epidemiology+Study+%28PiSCES%29&rft.jtitle=Pain+%28Amsterdam%29&rft.au=Jagtiani%2C+Ashna&rft.au=Chou%2C+Eric&rft.au=Gillespie%2C+Scott+E&rft.au=Liu%2C+Katie&rft.date=2024-10-01&rft.eissn=1872-6623&rft.volume=165&rft.issue=10&rft.spage=2364&rft_id=info:doi/10.1097%2Fj.pain.0000000000003262&rft_id=info%3Apmid%2F38787626&rft_id=info%3Apmid%2F38787626&rft.externalDocID=38787626
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1872-6623&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1872-6623&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1872-6623&client=summon